Literature DB >> 11348299

The Value of Fine Needle Aspiration Cytology in Breast Fibromatosis: Study of Two New Cases and Review of the Literature.

M. Zanella1, G. Falconieri, D. Della Libera.   

Abstract

We report two new cases of breast fibromatosis studied by needle aspiration cytology observed in a 32-year-old man and a 49-year-old woman. The lesions manifested as palpable, painless, and firm masses of the para-areolar breast soft tissues. Preoperative fine needle cytology revealed scant cellularity, featuring oval and spindle cells with bland nuclei and occasional larger polygonal cells with high nuclear:cytoplasmic ratio. Histologically, interwoven fascicles of spindle cells with bland nuclei, infiltrating the adjacent breast fat, were recognized. Based on available reports in the literature, we concluded that needle aspiration cytology, although not entirely specific, may be a source of important information in patients with breast fibromatosis. In particular, it confidently allows the exclusion of breast cancer and other more common diseases and is useful in planning a surgical approach to the lesion.

Entities:  

Year:  1999        PMID: 11348299     DOI: 10.1046/j.1524-4741.1999.97049.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  2 in total

1.  Multicentric aggressive mammary fibromatosis with cytological features and review of literature.

Authors:  Parul Garg; Sanjay Singh Chufal; Nilakshi Gupta; Prabhat Pant; Naveen Chandra Thapliyal
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 2.  Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature.

Authors:  Michael R Boland; Timothy Nugent; Jack Nolan; Johnny O'Mahony; Sylvia O'Keeffe; Charles C Gillham; Aoife Maguire; James Geraghty; Damian McCartan; Denis Evoy; Ruth S Prichard; Enda W McDermott; Dhaffir Alazawi; Terence J Boyle; Elizabeth M Connolly
Journal:  Breast Cancer       Date:  2020-08-11       Impact factor: 4.239

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.